Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tioguanine in the treatment of refractory coeliac disease--a single centre experience.
Tack GJ, van Asseldonk DP, van Wanrooij RL, van Bodegraven AA, Mulder CJ. Tack GJ, et al. Among authors: van asseldonk dp, van bodegraven aa, van wanrooij rl. Aliment Pharmacol Ther. 2012 Aug;36(3):274-81. doi: 10.1111/j.1365-2036.2012.05154.x. Epub 2012 May 30. Aliment Pharmacol Ther. 2012. PMID: 22646133 Free article.
Editorial: nocebo effect and switching to biosimilars.
van Bodegraven AA, Boone NW. van Bodegraven AA, et al. Aliment Pharmacol Ther. 2018 Mar;47(6):850-851. doi: 10.1111/apt.14509. Aliment Pharmacol Ther. 2018. PMID: 29446141 No abstract available.
Impacts of perianal disease and faecal incontinence on quality of life and employment in 1092 patients with inflammatory bowel disease.
Vollebregt PF, van Bodegraven AA, Markus-de Kwaadsteniet TML, van der Horst D, Felt-Bersma RJF. Vollebregt PF, et al. Among authors: van bodegraven aa, van der horst d. Aliment Pharmacol Ther. 2018 May;47(9):1253-1260. doi: 10.1111/apt.14599. Epub 2018 Mar 9. Aliment Pharmacol Ther. 2018. PMID: 29520808 Free PMC article.
Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies.
Simsek M, Deben DS, Horjus CS, Bénard MV, Lissenberg-Witte BI, Buiter HJC, van Luin M, Seinen ML, Mulder CJJ, Wong DR, de Boer NKH, van Bodegraven AA. Simsek M, et al. Among authors: van bodegraven aa, van luin m. Aliment Pharmacol Ther. 2019 Jul;50(1):54-65. doi: 10.1111/apt.15280. Epub 2019 May 16. Aliment Pharmacol Ther. 2019. PMID: 31094013 Free PMC article.
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry.
Biemans VBC, Sleutjes JAM, de Vries AC, Bodelier AGL, Dijkstra G, Oldenburg B, Löwenberg M, van Bodegraven AA, van der Meulen-de Jong AE, de Boer NKH, Srivastava N, West RL, Römkens TEH, Horjus Talabur Horje CS, Jansen JM, van der Woude CJ, Hoekstra J, Weersma RK, van Schaik FDM, Hoentjen F, Pierik MJ; Dutch Initiative on Crohn and Colitis (ICC). Biemans VBC, et al. Among authors: van schaik fdm, van der woude cj, van bodegraven aa, van der meulen de jong ae. Aliment Pharmacol Ther. 2020 May;51(9):880-888. doi: 10.1111/apt.15689. Epub 2020 Apr 1. Aliment Pharmacol Ther. 2020. PMID: 32237087 Free PMC article.
270 results